QVIDTVM Management LLC Purchases 197,803 Shares of DENTSPLY SIRONA Inc. (NASDAQ:XRAY)

QVIDTVM Management LLC lifted its position in DENTSPLY SIRONA Inc. (NASDAQ:XRAY) by 75.8% in the third quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor owned 458,866 shares of the medical instruments supplier’s stock after purchasing an additional 197,803 shares during the quarter. DENTSPLY SIRONA accounts for 8.7% of QVIDTVM Management LLC’s portfolio, making the stock its 5th largest position. QVIDTVM Management LLC owned about 0.23% of DENTSPLY SIRONA worth $12,417,000 at the end of the most recent reporting period.

Several other hedge funds and other institutional investors have also recently bought and sold shares of XRAY. UMB Bank n.a. lifted its stake in DENTSPLY SIRONA by 430.3% during the third quarter. UMB Bank n.a. now owns 928 shares of the medical instruments supplier’s stock worth $25,000 after purchasing an additional 753 shares during the period. Capital Performance Advisors LLP acquired a new stake in shares of DENTSPLY SIRONA during the third quarter worth approximately $27,000. LRI Investments LLC raised its position in DENTSPLY SIRONA by 82.7% in the 2nd quarter. LRI Investments LLC now owns 1,246 shares of the medical instruments supplier’s stock valued at $31,000 after purchasing an additional 564 shares during the last quarter. Rothschild Investment LLC acquired a new position in DENTSPLY SIRONA in the second quarter worth $32,000. Finally, Kennebec Savings Bank bought a new stake in shares of DENTSPLY SIRONA during the third quarter worth $35,000. 95.70% of the stock is owned by institutional investors.

DENTSPLY SIRONA Price Performance

NASDAQ XRAY opened at $19.52 on Tuesday. The company has a debt-to-equity ratio of 0.72, a current ratio of 1.25 and a quick ratio of 0.84. The business has a 50 day simple moving average of $23.25 and a 200 day simple moving average of $25.05. DENTSPLY SIRONA Inc. has a 52-week low of $17.21 and a 52-week high of $37.60.

DENTSPLY SIRONA (NASDAQ:XRAY) last announced its earnings results on Thursday, November 7th. The medical instruments supplier reported $0.50 earnings per share for the quarter, topping analysts’ consensus estimates of $0.48 by $0.02. DENTSPLY SIRONA had a negative net margin of 10.59% and a positive return on equity of 12.62%. The firm had revenue of $951.00 million during the quarter, compared to analyst estimates of $939.10 million. During the same period in the prior year, the business earned $0.49 EPS. The company’s revenue for the quarter was up .4% compared to the same quarter last year. As a group, analysts forecast that DENTSPLY SIRONA Inc. will post 1.84 EPS for the current fiscal year.

Analysts Set New Price Targets

Several analysts have recently commented on XRAY shares. Barrington Research decreased their price target on shares of DENTSPLY SIRONA from $36.00 to $24.00 and set an “outperform” rating on the stock in a research note on Friday, November 8th. Leerink Partners cut DENTSPLY SIRONA from an “outperform” rating to a “market perform” rating in a research note on Thursday, November 7th. Evercore ISI cut their price target on DENTSPLY SIRONA from $29.00 to $27.00 and set an “outperform” rating on the stock in a research note on Tuesday, October 8th. Needham & Company LLC lowered their price objective on DENTSPLY SIRONA from $34.00 to $29.00 and set a “buy” rating for the company in a research report on Friday, October 25th. Finally, Robert W. Baird cut their target price on shares of DENTSPLY SIRONA from $31.00 to $24.00 and set a “neutral” rating on the stock in a research report on Friday, November 8th. Seven analysts have rated the stock with a hold rating and three have assigned a buy rating to the company’s stock. According to data from MarketBeat.com, DENTSPLY SIRONA presently has an average rating of “Hold” and an average price target of $29.50.

DENTSPLY SIRONA Company Profile

DENTSPLY SIRONA Inc manufactures and sells various dental products and technologies worldwide. It operates in four segments: Connected Technology Solutions, Essential Dental Solutions, Orthodontic and Implant Solutions, and Wellspect Healthcare. The company offers dental equipment comprising imaging equipment, motorized dental handpieces, treatment centers, other instruments, amalgamators, mixing machines, and porcelain furnaces; and dental CAD/CAM technologies to support dental restorations, such as intraoral scanners, 3-D printers, mills, other software and services, and a full-chairside economical restoration of esthetic ceramic dentistry, as well as DS Core, its cloud-based platform.